Pepsi Pours $1.95B Into Prebiotic Pioneer Poppi While Traditional Sodas Fizzle
While traditional soda sales fizzle, PepsiCo is betting big on bubbles with benefits. On Monday, the beverage titan announced its $1.95B acquisition of prebiotic soda maker Poppi — diving headfirst into the “booming” gut-health drink market while directly challenging rival Coca-Cola’s new-found turf.
- PepsiCo ditched its in-house plans — opting instead to acquire a brand with $100M+ in annual sales, Super Bowl-level marketing clout, and a recent $8.9M lawsuit settlement over health claims.
- While probiotics like kombucha and kefir introduce new gut bacteria, prebiotic sodas feed existing microbes with plant-derived fibers — a category Coke projects to exceed $2B by 2029 as its Simply Pop brand battles with Poppi and Olipop.
Industry under pressure: With traditional soda sales slipping 1% from last year, PepsiCo’s acquisition comes amid intensifying regulatory headwinds. RFK Jr., the man behind the “Make America Healthy Again” initiative, calls traditional soda “poison” as he pushes states to exclude sugary drinks from food stamps inclusion. While Arkansas leads the counter-soda charge, Pepsi’s gut-health pivot strategically positions it against regulatory scrutiny and shifting consumer preferences — keeping profits fat and waists slim (allegedly).
